OTAVA Ltd. and Institute of Genetics and Molecular Medicine at University of Edinburgh Announce Research Collaboration
In terms of the project, OTAVA will perform virtual screening to identify a set of compounds that might display protein kinase inhibitory activity. In addition, OTAVA's scientists will carry out all tasks associated with organic synthesis and chemical optimization.
Scientists from Cancer Research UK-p53 Signal Transduction Laboratories are responsible for biological in vitro tests concerning determination of the kinase inhibitory activity of selected compounds including enzymatic assays and cell tests.
Topics
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.